Study of Erythromycin in GER-Associated Apnea of the Newborn
Status unconfirmed · Not applicable · Has a placebo group
Conditions studied: Gastroesophageal Reflux, Apnea, Bradycardia
In brief
To evaluate the relationship of reflux and apnea and to determine whether the administration of erythromycin improves the incidence of GER and GER-associated apnea, bradycardic and/or desaturation events in a prospective randomized controlled trial.
Key facts
- Study ID
- NCT01825473
- Run by
- University of Virginia
- People needed
- 40
- Starts
- 2012-09-01
- Expected to finish
- 2014-06-01
- Last updated by the study team
- 2013-04-05
Who can join
Age: 0 and older. Sex: any. Healthy volunteers: accepted.
You may not qualify if…
- major central nervous system, gastrointestinal, or complex cardiac anomalies
Where it is running
- University of Virginia Children's Hospital — Charlottesville, Virginia, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.